MedTrace Logo

MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors

NCT02076906 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-01-01

No results posted yet for this study

Summary

The purpose of this study is to determine if Magnetic Resonance guided High Intensity Focused Ultrasound ablative therapy is safe and feasible for children, adolescents, and young adults with refractory or relapsed solid tumors.

Conditions

  • Relapsed Pediatric Solid Tumors
  • Refractory Pediatric Solid Tumors
  • Rhabdomyosarcoma
  • Ewing Sarcoma
  • Osteosarcoma
  • Neuroblastoma
  • Wilms Tumor
  • Hepatic Tumor
  • Germ Cell Tumor
  • Desmoid Tumor

Interventions

DEVICE

Magnetic Resonance High Intensity Focused Ultrasound

MR-High intensity focused ultrasound (HIFU) is an ultrasound based technology which allows for non-invasive thermal ablation of tumors under the guidance of MR thermography.

Sponsors & Collaborators

  • AeRang Kim

    lead OTHER

Principal Investigators

  • AeRang Kim, MD, PhD · Children's National Research Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2021-12-27
Completion
2024-11-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02076906 on ClinicalTrials.gov